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Professional APCs are equipped with receptors 
that recognize, capture, and internalize antigens 
to facilitate their processing and presentation to 
T cells. Among APCs, DCs are unique in their 
capacity to stimulate naive T cells; however, their 
function is not restricted to the initiation of 
strong immune responses against pathogens, but 
also to regulate T cell homeostasis and prevent 
autoimmunity. Indeed, DCs efficiently support 
the in vitro generation and expansion of iT reg 
cells, regulate T reg cell homeostasis in vivo 
(Fehérvári and Sakaguchi, 2004; Cong et al., 
2005), and even induce T cell anergy (Hawiger 
et al., 2001). Targeting of antigen to resting 
DCs via DEC-205 resulted in an unsustained 
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Myelin oligodendrocyte glycoprotein (MOG), a constituent of central nervous system my-
elin, is an important autoantigen in the neuroinflammatory disease multiple sclerosis (MS). 
However, its function remains unknown. Here, we show that, in healthy human myelin, 
MOG is decorated with fucosylated N-glycans that support recognition by the C-type  
lectin receptor (CLR) DC-specific intercellular adhesion molecule-3–grabbing nonintegrin 
(DC-SIGN) on microglia and DCs. The interaction of MOG with DC-SIGN in the context of 
simultaneous TLR4 activation resulted in enhanced IL-10 secretion and decreased T cell 
proliferation in a DC-SIGN-, glycosylation-, and Raf1-dependent manner. Exposure of 
oligodendrocytes to proinflammatory factors resulted in the down-regulation of fucosyl-
transferase expression, reflected by altered glycosylation at the MS lesion site. Indeed, 
removal of fucose on myelin reduced DC-SIGN–dependent homeostatic control, and re-
sulted in inflammasome activation, increased T cell proliferation, and differentiation to-
ward a Th17-prone phenotype. These data demonstrate a new role for myelin glycosylation 
in the control of immune homeostasis in the healthy human brain through the MOG– 
DC-SIGN homeostatic regulatory axis, which is comprised by inflammatory insults that 
affect glycosylation. This phenomenon should be considered as a basis to restore immune 
tolerance in MS.
© 2014 García-Vallejo et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
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suggests that glycosylation plays a role in the control of pe-
ripheral tolerance to brain autoantigens. Induction of experi-
mental autoimmune encephalomyelitis, the animal model of 
MS, is much more efficient when recombinant unglycosyl-
ated myelin oligodendrocyte glycoprotein (MOG) is used, in 
contrast to native MOG (Smith et al., 2005). Also, alterations in 
glycosyltransferases (Husain et al., 2008; Brynedal et al., 2010) 
or glycan-binding proteins (Hoppenbrouwers et al., 2009) have 
been linked to a higher incidence of MS. Yet, the molecular 
mechanisms behind this association remain unclear.
Here, we show for the first time that a major autoantigen 
in MS, MOG, is recognized by DC-SIGN on APCs within 
the human brain, including microglia. The interaction results 
in the transmission of a tolerogenic signal characterized by 
increased IL-10 secretion and decreased T cell proliferation. 
Conversely, myelin particles lacking DC-SIGN ligands in-
duce immunogenic signals characterized by inflammasome 
activation and enhanced T cell proliferation. Our results help 
to explain how an immunosuppressive milieu in the healthy 
human CNS is maintained through the glycosylation status of 
MOG/myelin that engages DC-SIGN, keeping local APCs in 
an immature nonpathogenic state.
RESULTS
DC-SIGN is expressed on microglia  
in the resting human brain
DC-SIGN has been classically described as a human DC 
marker in peripheral tissues, such as skin and mucosa, and in 
lymphoid organs (Soilleux et al., 2002; Engering et al., 2004). 
In the brain, DC-SIGN is expressed on CD163+ perivascular 
macrophages (Fabriek et al., 2005a), meningeal DCs (Serafini 
et al., 2006), and in vitro–cultured microglia (Lambert et al., 
2008). Using the polyclonal antibody CSRD against the C 
terminus of DC-SIGN (Engering et al., 2004), as well as two 
mAbs against the stalk region of DC-SIGN, we sought to de-
termine if DC-SIGN is expressed in normal human brain. 
Immunohistochemical analysis demonstrated a pattern of 
DC-SIGN+ small cells scattered throughout the brain paren-
chyma, with little perinuclear cytoplasm and branched pro-
cesses covered with fine protrusions (Fig. 1 a, arrows), being 
distinctive features of microglia. Preblocking CSRD with re-
combinant soluble DC-SIGN completely abolished staining, 
verifying antibody specificity (Fig. 1 b). Relatively large cells 
within perivascular spaces were also stained, suggestive of 
perivascular macrophages (Fig. 1 b, arrow). Colocalization of 
DC-SIGN and HLA-DR, a constitutive marker of microglia, 
confirmed the identity of these cells as microglia (Fig. 1 c). 
Moreover, high levels of DC-SIGN could be demonstrated 
on primary human microglia (MHC-II+CD11c+GSL-I 
isolectin B4+) isolated from a surgical brain biopsy (Fig. 1 d). 
Expression of DC-SIGN at the transcript level could also 
be demonstrated in microglia isolated from cryosections by 
laser-capture microdissection of MHC-II+ cells and also in 
primary microglia from human brain tissue (Fig. 1 e). DC-
SIGN transcripts were considerably less abundant in microglia 
expansion of antigen-specific CD4+ T cells that did not dif-
ferentiate into effector cells (Hawiger et al., 2001). Similar 
functional unresponsiveness was observed in naive antigen-
specific CD8+ T cells when splenic lymphoid DCs were ex-
posed to dying cells loaded with cognate antigen (Liu et al., 
2002). Unfortunately, reports on DC-lacking mice are contro-
versial (Birnberg et al., 2008; Ohnmacht et al., 2009) and the 
precise role of DCs in the maintenance of peripheral tolerance in 
humans remains to be determined.
C-type lectin receptors (CLRs), such as DEC-205 and DC-
specific intercellular adhesion molecule-3–grabbing nonintegrin 
(DC-SIGN), have been proposed to play an important role in 
homeostatic control. DC-SIGN is a type II transmembrane 
receptor equipped with a Ca2+-dependent mannose-binding 
carbohydrate recognition domain with specificity for anti-
gens decorated with high-mannose or Lewis-type structures 
(Appelmelk et al., 2003). Signaling crosstalk with TLRs has been 
demonstrated for DC-SIGN and some other CLRs on DCs 
(Geijtenbeek and Gringhuis, 2009). Although eight mouse ge-
netic homologues are known (Park et al., 2001; Powlesland et al., 
2006), none has the same glycan specificity, expression profile, or 
signaling properties as human DC-SIGN (García-Vallejo and 
van Kooyk, 2013). Hence, knowledge on the physiological func-
tions of DC-SIGN is based on human in vitro data. Contrary 
to other antigen-uptake receptors, pathogen recognition by 
DC-SIGN often results in immune escape (van Kooyk and 
Geijtenbeek, 2003; Rappocciolo et al., 2008; Wang et al., 2008) 
and the carbohydrate ligands of DC-SIGN are also found on 
host glycoproteins, suggesting that DC-SIGN participates in the 
control of immune homeostasis (García-Vallejo and van Kooyk, 
2009). Interaction of DC-SIGN with its ligands on immune 
cells mediates adhesion and favors communication during 
(cognate) interactions. DC-SIGN ligands on nonimmuno-
logical tissues, such as the tumor-associated epithelial proteins 
CEA and CEACAM1 (van Gisbergen et al., 2005) can enhance 
the cytokine response of DCs to the TLR4 ligand LPS in a simi-
lar way, as previously reported for the M. tuberculosis DC-SIGN 
ligand ManLAM, by synergistically increasing the LPS- 
mediated secretion of IL-10 (Geijtenbeek et al., 2003). Addi-
tionally, supernatants from CEA and CEACAM1-producing 
cell lines inhibited DC maturation and attenuated Th1 skewing 
(Nonaka et al., 2008). Apparently, both tumor and pathogens 
have ways to escape immune activation by targeting a receptor 
that is able to transform proinflammatory into tolerogenic sig-
nals. DC-SIGN has therefore been proposed to be a homeostatic 
receptor that can be subverted by pathogens and tumors through 
changes in their glycan phenotype. However, DC-SIGN has not 
yet been found to recognize any autoantigen, or to support any 
role in the maintenance of peripheral tolerance in humans.
The central nervous system (CNS) has evolved as an 
immune-privileged site to protect its vital functions from detri-
mental insults, by immune-mediated inflammation. Microglia 
are CNS-based APCs that continuously evaluate local changes 
in the CNS to activate the immune system during injury 
(Olson and Miller, 2004) or to maintain homeostasis in the 
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CD163 (unpublished data). These data demonstrate that DC-
SIGN is expressed on both microglia and perivascular macro-
phages in healthy human brain, closely associated with highly 
myelinated areas.
as compared with DCs (Fig. 1 e). As expected, macrophages 
did not express DC-SIGN (Fig. 1 e). Primary microglia and 
laser-captured MHC-II+ cells were negative for the astro-
cyte marker GFAP and the perivascular macrophage marker 
Figure 1. DC-SIGN is expressed on micro-
glia. (a) Frozen healthy human brain sections were 
stained for DC-SIGN with the polyclonal antibody 
CSRD and imaged by immunohistochemistry. 
Arrows highlight typical microglia features (rep-
resentative of n > 7 donors). (b) Frozen healthy 
human brain sections were stained for DC-SIGN 
with CSRD with or without recombinant DC-SIGN 
and imaged by immunohistochemistry. The arrow 
highlights a perivascular macrophage (represen-
tative of n > 7 donors). (c) Frozen healthy human 
brain sections were stained for DC-SIGN (green) 
and MHC-II (red) and imaged by immunofluor-
escence microscopy. Three different anti–DC-SIGN 
antibodies were used: CSRD (polyclonal), DC-4 
and DC-28 (mAbs against the stalk region; repre-
sentative of n > 7 donors). (d) Primary microglia 
were isolated from a brain biopsy; stained for DC-
SIGN, MHC-II, CD11c, and GSL-I Isolectin B4; and 
analyzed by FACS. DCs were analyzed in parallel 
for comparison (representative of triplicate deter-
mination). (e) DC-SIGN transcripts were quanti-
fied by real time RT-PCR after laser-capture 
microdissection of MHC-II+ cells from frozen 
normal brain sections (pool of 3 donors) and pri-
mary microglia as in d. Data are the mean ± SD  
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(Fig. 2 a). The particles generated with this protocol con-
tained the myelin proteins MOG and PLP and lacked 
other cell-type markers (Fig. 2 b). Further characterization 
by electron microscopy showed that myelin particles adopt 
a liposome-like shape of heterogeneous size distribution, 
DC-SIGN recognizes glycan structures  
on human healthy myelin
To investigate the functional implications of DC-SIGN ex-
pression on APCs within the brain, we isolated myelin from 
healthy human brain by a sucrose gradient centrifugation 
Figure 2. Characterization of human myelin. (a) Myelin was prepared by homogenization of fresh human white matter and sucrose gradient cen-
trifugation, as indicated in the scheme. (b) The resulting myelin particles were characterized by FACS using microglial (MOG and PLP), endothelial (CD31), 
microglial (MHC-II), astrocytic (GFAP) or neuronal (NGFR) markers (representative of n > 3 donors). (c) Transmission electron micrograph of myelin par-
ticles (representative of n > 3 donors). (d) The diameter of 100 myelin particles was measured in 10 different micrographs. Data are the mean ± SD (n = 3 
independent experiments). (e) Myelin was coated on to ELISA plates and the binding of DC-SIGN measured by a DC-SIGN–binding assay as described in 
the Materials and methods. *, P ≤ 0.05 (Mann-Whitney U test). Data are the mean ± SD (n = 3 independent experiments). (f) Binding of a titration of 
atto633-labeled myelin to DC-SIGN–expressing DCs was measured by FACS. Data are the mean ± SD (n = 3 independent experiments). (g) DCs were incu-
bated with myelin (10 µg/ml), the DC-SIGN ligand PAA-LeX (10 µg/ml), or the MGL-ligand PAA-GalNAc (10 µg/ml), washed, and fixated. Binding of the 
DC-SIGN–specific antibodies AZN-D1 (mAb against carbohydrate-recognition domain) and CSRD (polyclonal against C terminus) was determined by 
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down-regulating fucosyltransferase expression on oligodendro-
cytes and, therefore, decreasing the amount of fucosylated DC-
SIGN ligands on myelin glycoproteins.
MOG is a ligand for DC-SIGN on human myelin
Among the glycoproteins present in myelin that could sup-
port DC-SIGN binding, we speculated that MOG could be 
an interesting candidate. MOG is a type I membrane ho-
modimer on the outermost surface of the myelin sheath. Both 
glycans on the homodimer (Asn31) are localized to the top of 
the structure (Clements et al., 2003). The close proximity of 
both glycans in the dimer and the presence of MOG in lipid 
rafts (Kim and Pfeiffer, 1999) suggest that MOG-rich micro-
domains could display their glycans in multivalent form, providing 
a potentially high-avidity binding platform for carbohydrate-
binding proteins. Because the glycosylation of MOG has been 
poorly characterized we first set out to investigate the glycan 
composition of MOG. For this purpose, MOG was immuno-
precipitated using the mAb Z12 and its glycans were sequenced. 
The majority of the glycans identified contained one or two 
terminal fucoses, corresponding to the typical Lewis-type DC-
SIGN ligands already described on myelin (unpublished data).
To investigate whether MOG is involved in interactions 
with DC-SIGN, we tested the binding of soluble DC-SIGN 
to myelin isolated from brains of C57BL/6 WT and Mog/ 
mice by FACS. Results clearly show that DC-SIGN binds to 
WT myelin but not to Mog/ myelin, indicating that MOG 
is the sole ligand of DC-SIGN on myelin (Fig. 3, e and f ).
To study if the interaction of MOG and DC-SIGN is 
glycosylation-dependent, we expressed MOG on Lec12 cells, 
which overexpress Lewis-type glycans due to a gain-of-function 
mutation in FUT-IX (Patnaik et al., 2004), or CHO cells, which 
lack Lewis-type glycans (North et al., 2010). MOG expres-
sion in both cell lines was verified by staining with the MOG-
specific mAb Z12 (Fig. 3 g). A sandwich ELISA was then 
designed using Z12 as a capture antibody and recombinant 
soluble DC-SIGN for detection. Results demonstrate that 
only MOG modified with fucosylated glycans binds DC-
SIGN (Fig. 3 h). These data demonstrate that human MOG is 
a ligand for DC-SIGN when properly glycosylated.
DC-SIGN interacts only with large myelin  
particles and mediates internalization
As shown in Fig. 2 (c and d), myelin particles adopt liposome-
like structures in a large range of size and complexity. Interest-
ingly, only large myelin particles display high levels of MOG, 
bind the (1–3, 4)fucose-specific plant lectin LTA, and are 
able to bind soluble DC-SIGN (Fig. 4 a). Small myelin parti-
cles show hardly any MOG and no DC-SIGN binding, which 
is consistent with a lack of fucose as illustrated by the poor 
LTA staining (Fig. 4 a).
Differences in MOG expression and DC-SIGN binding 
related to the myelin particle size can be explained by the as-
sociation of MOG to lipid rafts (Kim and Pfeiffer, 1999) 
which, because of their size (Simons and Vaz, 2004), are exclu-
sively present in large myelin particles. Upon exposure to 
with 50–100 nm as the most frequent particle diameter (Fig. 2, 
c and d).
Because DC-SIGN has been shown to recognize ligands 
on both self- and nonself-glycoproteins, we decided to explore 
the presence of DC-SIGN ligands on myelin using an ELISA-
based DC-SIGN–binding assay. Results indicate that DC-
SIGN binds to myelin in a Ca2+-dependent manner (Fig. 2 e), 
as expected for a CLR. Furthermore, binding could be blocked 
with the DC-SIGN ligand mannan or a blocking anti–DC-
SIGN antibody (AZN-D1), but not with an irrelevant carbo-
hydrate or an isotype control (Fig. 2 e). To investigate if myelin 
also binds cellular DC-SIGN, myelin particles were labeled 
with atto633 and binding to DCs was addressed by FACS. Re-
sults demonstrate that myelin was recognized by DCs in a con-
centration- and DC-SIGN–dependent manner, as the binding 
was completely inhibited by preincubation of DCs with the 
DC-SIGN blocking antibody AZN-D1 (Fig. 2 f ).
A previous study using the mAb AZN-D1 failed to iden-
tify DC-SIGN expression on microglia (Fabriek et al., 2005a). 
However, using three different antibodies targeting DC-
SIGN domains that are not involved in carbohydrate recogni-
tion, our data unequivocally demonstrate the presence of 
DC-SIGN on microglia. A plausible explanation for this con-
troversy could be that the epitope of AZN-D1 on DC-SIGN 
(the carbohydrate recognition domain) is occupied by its li-
gand. To test this possibility, we incubated DCs with myelin 
particles or the well-known DC-SIGN ligand LeX-PAA and 
subsequently stained the cells with either AZN-D1 or CSRD. 
Incubation with myelin particles or LeX-PAA resulted in a 
similar decrease in AZN-D1 staining, whereas staining with 
CSRD was not affected at all (Fig. 2 g). These data suggest 
that DC-SIGN on healthy CNS microglia is engaged in con-
tinuous interaction with myelin.
To characterize the carbohydrate ligands of DC-SIGN 
we performed a quantitative glycan profiling of human CNS 
myelin (Fig. 3, a and b). Strikingly, the variety of Lewis-type 
antigen-containing glycans (3/4-fucosylated branch structures) 
was unusually rich as compared with other tissues (http://www 
.functionalglycomics.org). The presence of highly fucosylated 
glycans was confirmed by lectin ELISA, as shown by the bind-
ing of the fucose-specific plant lectins LTA, UEA-I, and AAL, 
as well as with a LewisX-specific mAb (Fig. 3 c).
Glycosylation is often subjected to regulation by inflamma-
tory mediators. To investigate if the glycosylation of myelin is 
sensitive to common proinflammatory mediators, we assessed 
the expression of the glycosyltransferases involved in the syn-
thesis of DC-SIGN ligands on primary oligodendrocytes ob-
tained from rhesus macaques exposed to TNF or IL-6. Rhesus 
macaque oligodendrocytes were used because of their close ge-
netic proximity to humans. Treatment of primary oligodendro-
cytes with proinflammatory cytokines resulted in a marked 
down-regulation of the transcripts for the fucosyltransferases 
FUT-1 (GeneID: 2523) and FUT-4 (GeneID: 2526; Fig. 3 d). 
Similar results were obtained using the human oligodendrocyte 
cell line MO3.13 (unpublished data). These results indicate that 
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Figure 3. Myelin is rich in N-glycans carrying DC-SIGN–binding carbohydrates. (a) N-glycans were enzymatically released, purified, fluorescently 
labeled, and profiled by LC-MS. Data are representative of the profiles of three myelin preparations. (b) The relative distribution of the main categories of 
N-glycans; high-mannose (HM), hybrid-type (HT), and Lewis antigen (Le) containing complex type N-glycans, was determined in three myelin prepara-
tions. Data are shown as the mean ± SD (n = 3 independent experiments). (c) Myelin was coated on to plates and the binding of the fucose-specific plant 
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with signaling pathways other than TLR4, such as IFNR1, 
IL-6R, or IL-17R. However, with the exception of LPS, none 
of the stimuli tested in combination with myelin had any ef-
fect on the expression of IL-10 (Fig. 5 n).
The three-dimensional orientation of MOG N-glycans 
and the enrichment of MOG homodimers in lipid rafts con-
tribute to highly multivalent DC-SIGN ligands on myelin. 
The presentation of glycan epitopes in high density and 
number are important determinants of the binding and effec-
tor functions of lectins (Dam and Brewer, 2010). To investi-
gate if the interaction of DC-SIGN with its carbohydrate 
ligand is positively influenced by multivalency, we designed 
glycodendrimers carrying a typical fucose-containing DC-
SIGN ligand (Leb), similar to those present on MOG and 
myelin. Incubation of the DC-SIGN–expressing DCs with 
Leb glycodendrimers did not affect the expression of co-
stimulatory molecules and maturation markers or the expres-
sion and secretion of cytokines (unpublished data). However, 
when DCs were exposed to Leb glycodendrimers in the pres-
ence of the TLR4 ligand LPS we observed an effect that was 
similar to that of myelin, namely a synergistic increase in the 
expression (not depicted) and secretion of the antiinflamma-
tory cytokine IL-10 (Fig. 6 a), whereas none of the other cy-
tokines were affected (not depicted). We further verified that 
the synergistic increase in IL-10 expression upon simultane-
ous stimulation with myelin and LPS resulted also in a syner-
gistic increase in IL-10 secretion (Fig. 6 b), but did not have 
any effect on the secretion of other cytokines such as IL-1, 
IL-6, IL-8, IL-12p70, IL-23, TNF, or TGF (not depicted). 
Since only MyHi DCs are affected by the interaction of DC-
SIGN with its ligands on myelin, we hypothesized that only 
MyHi DCs could synergistically increase IL-10 expression 
upon simultaneous incubation with myelin and LPS. To test 
this, we exposed DCs to atto633-labeled myelin with or 
without LPS and sorted the DCs according to myelin con-
tent. As expected, only large myelin particles modulated the 
signaling elicited by LPS on DCs, supporting the hypothesis 
that multivalency enhances DC-SIGN binding and function-
ality (Fig. 6 c). This phenomenon may have an in vivo corre-
late, as the DC-SIGN+ cells in human normal brain also 
express IL-10 (Fig. 6 d), presumably as a result of the trigger-
ing of DC-SIGN by its myelin ligand MOG. In conclusion, 
our data demonstrate that DC-SIGN-mediated binding of 
myelin to DCs in the context of TLR4 ligation results in se-
lective up-regulation of IL-10 expression and secretion, both 
in vitro and in vivo.
DC-SIGN–expressing APCs, myelin particles are quickly 
internalized. A fraction of DCs internalize exclusively the 
smaller myelin particles that cannot be detected by confocal 
microscopy, but can still be measured by FACS (MyLo; Fig. 4 b). 
Importantly, some DCs accumulate large myelin particles, 
as determined by FACS and confocal microscopy of MyHi 
FACS-sorted DCs (MyHi; Fig. 4 b). Using FACS imaging, we 
investigated whether large myelin particles are internalized 
and if they followed the classical endolysosomal routing pre-
viously described for DC-SIGN (Engering et al., 2002; Cambi 
et al., 2009). Results demonstrate that the localization of my-
elin particles in MyHi DCs is fully intracellular (Fig. 4 c) and 
that myelin colocalizes with DC-SIGN at an early time-point 
(Fig. 4 d) and with the lysosomal marker LAMP-1 after 1 h 
(Fig. 4, e and g). Furthermore, MyHi DCs contain 18 myelin 
particles per cell, irrespective of co-incubation with LPS 
(Fig. 4 f). These data demonstrate that the interaction of DC-
SIGN with large myelin particles leads to internalization and 
routing to the endolysosomal pathway. Interaction of small 
myelin particles with DCs is independent of DC-SIGN and 
presumably results in internalization via pinocytosis or other 
nonspecific mechanisms.
Interaction of myelin with DC-SIGN–expressing  
APCs modulates the LPS-mediated expression  
and secretion of IL-10
The interaction of DC-SIGN with its ligands is accompanied 
by signaling events (Caparrós et al., 2006; Gringhuis et al., 
2007, 2009) that modify the response of DCs to LPS. To 
investigate if myelin binding triggers such responses, we first 
addressed the presence of LPS in our myelin preparation using 
a HEK293-TLR4-CD14 transfected cell line that secretes 
IL-8 upon triggering of TLR4 (Latz et al., 2002). All myelin 
preparations were devoid of TLR4 ligands (Fig. 5 a). We then 
exposed DCs to myelin in the presence or absence of the 
well-characterized TLR4 ligand LPS and analyzed the expres-
sion of IL-1, IL-6, IL-8, IL-10, IL12p35, IL-12p40, IL-18, 
IL-23p19, EBI3, IL-33, TNF, and TGF (Fig. 5, b–m). Inter-
estingly, stimulation with both myelin and LPS resulted in a 
synergistic increase in the expression of IL-10 (Fig. 5 e) and 
had no effect on other cytokines. To test whether myelin trig-
gered DC maturation, the expression levels of CD80, CD83, 
CD86, and MHC-I and MHC-II were investigated by FACS. 
Incubation of DCs with myelin with or without LPS did not 
affect the expression profile of any of the assayed markers 
(unpublished data). We also investigated if myelin interfered 
are shown as the mean ± SD (n = 3 independent experiments). (d) Primary oligodendrocytes were freshly isolated from rhesus macaques and cultured in 
the presence of TNF (100 IU/ml) for up to 18 h. The expression levels of the glycosyltransferases involved in the synthesis of Lewis-type epitopes were 
determined by real time PCR. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD (n = 3 independent experiments). (e and f) The binding 
of DC-SIGN to myelin from WT or MOG/ C57Bl6 mice was determined by FACS. (g) Representative of three independent experiments. (h) Mean ± SD of 
the relative binding. *, P ≤ 0.05 (Mann-Whitney U test; n = 3 independent experiments). (g) A human full-length MOG construct was expressed on CHO 
cells or a glycosylation mutant (Lec12). The expression of MOG was verified by FACS using the mAb Z12. Representative of three independent experi-
ments. (h) MOG was captured on Z12-coated plates and DC-SIGN binding was assessed by ELISA. Data are shown as the mean ± SD. *, P ≤ 0.05 (Mann-
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Figure 4. DC-SIGN mediates internalization and endolysosomal routing of large myelin particles. (a) Myelin particles were gated into large (R1) 
and small (R2) myelin particles and the level of MOG, and the presence of Lotus tetragonolobus agglutinin (LTA)-reactive structures (fucosylated glycans) 
and DC-SIGN ligands were addressed. Data are representative of three independent experiments. Thick lines represent cells stained with MOG, the LTA 
lectin, or soluble DC-SIGN, whereas thin lines represent the corresponding isotype or unstained controls. (b) DCs were exposed to atto633-labeled myelin 
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To test whether the effects observed in IL-10 expression 
and secretion were DC-SIGN dependent, we used the anti–
DC-SIGN blocking antibody AZN-D1 or the Raf-1 phos-
phorylation inhibitor GW5074. Preincubation of DCs with 
AZN-D1 or GW5074 before exposure to myelin and LPS 
resulted in blockade of the synergistic expression and secre-
tion of IL-10 as well as decreased T cell proliferation, likely 
caused by an increased frequency of anergic/suppressor 
T cells (Fig. 7, d–f). Moreover, the DC-SIGN-dependent up-
regulation in IL-10 secretion is responsible for the decreased 
T cell proliferation (unpublished data). Therefore, the effect of 
the simultaneous stimulation with myelin and a TLR4 ligand 
on DCs is the triggering of an antiinflammatory response 
characterized by high IL-10 levels and the generation of anergic/ 
suppressor T cells.
The loss of MOG-DC-SIGN interaction results  
in the activation of strong proinflammatory signals
We showed that proinflammatory stimuli induce down-regulation 
of fucosyltransferase transcripts (Fig. 3 d) and that myelin con-
taining less fucosylated glycans are not recognized by DC-SIGN 
(Fig. 4 a). We therefore hypothesized that fucosidase-treated 
myelin would lack the antiinflammatory effects of healthy 
myelin. Indeed, fucosidase treatment reduced binding to the 
fucose-specific lectins LTA and UEA-I, correlating with de-
creased recognition by DC-SIGN (Fig. 8 a). Furthermore, 
exposure of DCs to fucosidase-treated myelin resulted in a 
lack of synergistic effect on the LPS-mediated expression 
(Fig. 8 b) and secretion (Fig. 8 c) of IL-10 and abrogated the 
myelin-induced decrease in T cell proliferation observed in 
the anergy/T reg assay (Fig. 8 d). These data demonstrate that 
the glycan-dependent interaction of myelin with DC-SIGN 
is necessary for the antiinflammatory effects triggered by my-
elin on DCs.
Interestingly, LPS-treated MyLo DCs expressed very low 
levels of IL-10, much lower than LPS-treated DCs. We there-
fore investigated whether any proinflammatory pathways might 
be activated in these cells. Th17 responses have been demon-
strated to be crucial in the development of MS and experi-
mental autoimmune encephalomyelitis (Becher and Segal, 
2011). Because Th17 cells are dependent on IL-1 for their 
development (van Beelen et al., 2007), we explored whether 
the inflammasome, which is necessary for the secretion of 
bioactive IL-1 (Martinon et al., 2002), was activated in MyLo 
We further investigated the presence of DC-SIGN+ cells 
and fucosylated glycans in MS active lesions (Fig. 6, e–j). In-
terestingly, the demyelinated area corresponding to an MS le-
sion was rich in DC-SIGN+ cells (Fig. 6 h), which appeared as 
foamy macrophages (Fig. 6 i), a phenotype previously associ-
ated to antiinflammatory functions (Boven et al., 2006). More-
over, intact myelin showed a PLP-like staining for LTA (Fig. 6 f ) 
and LewisX-containing glycans (Fig. 6 g), whereas the center 
of the lesion was rich in a dense network of reactive astrocytes 
that were strongly positive for LTA (Fig. 6 f) and LewisX 
(Fig. 6 g). To investigate if astrocytes also express DC-SIGN 
ligands, we studied the binding of DC-SIGN to primary 
human astrocytes in vitro. Results demonstrate that, although 
astrocytes were rich in fucosylated structures that commonly 
serve as ligands for DC-SIGN, DC-SIGN was unable to bind 
these cells (Fig. 6 k). Incubation of astrocytes with high con-
centrations of TNF and IFN-, which results in a reactive 
phenotype (Sofroniew, 2009), significantly enhanced their fu-
cosylation, but failed to induce any DC-SIGN binding (Fig. 6 l), 
probably due to a concomitant increase in sialylation that 
may result in the capping or masking of any potential DC-
SIGN ligands and/or the absence of a proper protein scaffold 
for the carbohydrate ligands of DC-SIGN. Together with 
Fig. 3 (g–h), these data demonstrate that DC-SIGN binding 
requires not only a certain glycosylation, but also a specific 
protein scaffold, in this case MOG, reinforcing the importance 
of this glycoprotein as DC-SIGN ligand.
The combination of myelin and a TLR4 ligand  
triggers tolerogenic signaling on DCs
High IL-10 expression and secretion is the hallmark of toler-
ogenic APCs. Therefore, we investigated the effect of myelin 
or Leb glycodendrimers exposure on T cell proliferation in a 
secondary MLR. CD4+ T cells exposed to DCs pulsed with 
myelin or Leb glycodendrimers showed decreased capacity to 
proliferate in response to a second stimulation with fully 
activated DCs (Fig. 7, a and b). This was interpreted as the 
induction of anergic T cells or T reg cells during the primary 
MLR. As expected, sorted MyHi DCs induced generation of 
anergic/suppressor T cells (Fig. 7 c). These data indicate that 
recognition of myelin glycans by DC-SIGN expressing APCs 
can induce tolerance under inflammatory conditions through 
the induction of IL-10 and T cells with suppressor/inhibi-
tory capacity.
FACS. Myelin uptake defined two DC populations, MyHi and MyLo, which were subsequently stained for MHC-II (green) and investigated by confocal mi-
croscopy (blue, myelin). Data are representative of three independent experiments. (c) DCs were exposed to atto633-labeled myelin (10 µg/ml) for 1 h and 
the internalization of myelin in MyHi DCs was determined by imaging flow cytometry. As control, DCs incubated at 4 or 37°C with the DC-SIGN–blocking 
antibody AZN-D1 (10 µg/ml) were used. Data are based on at least 5,000 cells. Results are representative of three independent experiments. (d) DCs were 
exposed to atto633-labeled myelin (10 µg/ml) for 5 min, stained for DC-SIGN with the CSRD antibody, and tested for co-localization by imaging flow 
cytometry. Data are based on at least 5,000 cells. Results are representative of three independent experiments. (e) DCs were exposed to atto633-labeled 
myelin (10 µg/ml) for 1 h, stained for the lysosomal marker LAMP-1, and tested for colocalization by imaging flow cytometry. As control, DCs incubated 
at 4 or 37°C with AZN-D1 (10 µg/ml) were used. Data are based on at least 5,000 cells. Results are representative of three independent experiments.  
(f) DCs were incubated with atto633-labeled myelin (10 µg/ml) for 1 h in the presence or absence of LPS (10 ng/ml) and acquired by imaging flow cytom-
etry. A mask was designed to detect myelin particles and the number of myelin particles per cell was counted. Data are based on at least 5,000 cells. Results 
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Figure 5. Myelin enhances the LPS-mediated expression of IL-10 by DCs. (a) HEK-TLR4 cells were exposed to different preparations of myelin  
(10 µg/ml) and assayed for IL-8 production by ELISA. A titration of LPS was used as positive control. Data are shown as the mean ± SD (n = 3 independent 
experiments). (b–m) DCs were exposed to myelin (10 µg/ml) with or without LPS (10 ng/ml) for 6 h and analyzed by real-time PCR for the expression of 
IL-1 (b), IL-6 (c), IL-8 (d), IL-10 (e), IL-12p35 (f), IL-12p40 (g), IL-18 (h), IL-23p19 (i), EBI3 (j), IL-33 (k), TNF (l), and TGF (m). *, P ≤ 0.05 (Mann-Whitney  
U test). Data are shown as the mean the mean ± SD (n = 7 independent experiments). (n), DCs were exposed to myelin (10 µg/ml) with or without LPS (10 ng/ml), 
IFN (1,000 IU/ml), IL-6 (100 IU/ml), or IL-17 (100 IU/ml) for 6 h. The expression levels of IL-10 were determined by real time PCR. *, P ≤ 0.05 (Mann- 
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Figure 6. Simultaneous DC-SIGN and TLR4 triggering enhances IL-10 production. (a) DCs were incubated overnight with Lewisb-containing glyco-
dendrimers (10 µg/ml) or a mock control (maltoheptaose dendrimer, 10 µg/ml) in the presence or absence of LPS (10 ng/ml). Supernatants were assayed 
for IL-10 secretion by ELISA. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD (n = 6 independent experiments). (b) DCs were incu-
bated overnight with myelin (10 µg/ml) with or without LPS (10 ng/ml). Supernatants were harvested and assayed for IL-10 secretion by ELISA. *, P ≤ 0.05 
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(10 µg/ml) in the presence or absence of LPS (10 ng/ml). DCs were then sorted according to the amount of myelin ingested into MyHi and MyLo DCs and 
lysed for mRNA isolation. The expression levels of IL-10 were determined by real-time PCR. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the 
mean ± SD (n = 3 independent experiments). (d) Frozen healthy human brain sections were stained for DC-SIGN and IL-10 and imaged by confocal mi-
croscopy (representative of n = 3 donors). (e–j) Consecutive brain sections from a MS patient were stained with for PLP, fucosylated glycans (LTA, LeX), 
and DC-SIGN and imaged by standard microscopy (representative of 7 donors). The MS lesion (L) is highlighted with a dotted line. (k) Primary human 
astrocytes were stained for LewisX, and the binding of soluble DC-SIGN and the lectins MAA, SNA, and LTA was investigated by FACS (representative of 
three experiments). (l) Primary human astrocytes were cultured in the presence of TNF (100 IU/ml) and IFN- (1,000 IU/ml) for 48 h. The expression of 
LewisX and the binding of soluble DC-SIGN and the lectins LTA, MAA, and SNA was addressed by FACS. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown 
as the mean ± SD of the fold increase versus the untreated sample (n = 3 experiments).
 
DC-SIGN. The presentation of several fucoses in the branches 
of N-glycans provides the opportunity for high avidity interac-
tions that are essential for an efficient interaction of DC-SIGN 
with its ligands, and may contribute to increased recruitment 
of signaling molecules (Dam and Brewer, 2010).
We have focused our study on MOG, which despite its 
low abundance in CNS myelin is the dominant ligand of 
DC-SIGN in healthy human myelin. The glycan species iden-
tified on MOG carry one or two fucoses per branch, therefore 
providing the necessary avidity needed for proper interaction 
with DC-SIGN. Avidity may be increased at different levels: 
by the occurrence of MOG as a homodimer (Clements et al., 
2003) and its accumulation in lipid rafts (Kim and Pfeiffer, 
1999). This was clearly observed by the accumulation of MOG 
on large myelin particles, which, due to their size, are the only 
ones able to carry lipid rafts on the surface (Fan et al., 2010). 
Consistently we observed that only large myelin particles inter-
acted with DC-SIGN. Leb glycodendrimers mimicked the effect 
of myelin on DC-SIGN–expressing APCs, reinforcing the idea 
that ligand multivalency is essential for DC-SIGN function.
The vast majority of the general population does not de-
velop autoimmune attacks against myelin. However, autoreac-
tive T cells and antibodies specific for myelin constituents 
have been found in both MS and healthy patients. Therefore, 
mechanisms that prevent autoimmunity must exist in healthy 
individuals. These mechanisms are likely to work by prevent-
ing the activation and proliferation of autoreactive T cells. To 
date, our knowledge of these mechanisms remains limited. In 
particular, microglia have been reported to play a role in the 
regulation of homeostasis within the healthy CNS by removing 
cell debris. While performing this task, activation of microglia 
is prevented to maintain an antiinflammatory/immunosup-
pressive milieu. We postulate that the resting state of microglia 
within the healthy CNS white matter is secured by the inter-
action of DC-SIGN with glycosylated myelin, and MOG in 
particular. This interaction is likely to occur in the brain 
parenchyma, where DC-SIGN expression is abundant and 
seems to be closely associated to its ligand on myelin, as indi-
cated by the difference in staining with AZN-D1 (a blocking 
antibody) and other nonblocking anti–DC-SIGN antibodies 
(CSRD, DC-4, and DC-28). Interaction of DC-SIGN with 
myelin via MOG relays an antiinflammatory signal that re-
sults in the induction of anergic/suppressive T cells. Microglia 
triggered via DC-SIGN may therefore contribute to the 
intracerebral homeostatic control of CNS-infiltrating T cells. 
DCs. Using a fluorescently labeled caspase-1 inhibitor, we 
tested whether inflammasomes were activated in DCs ex-
posed to atto633-labeled myelin and LPS. Interestingly, only 
MyLo DCs showed activation of caspase-1, which was en-
hanced by co-incubation with LPS (Fig. 8 e). In agreement 
with these results, MyLo DCs did not reduce T cell prolifera-
tion in our anergy/T reg cell assay; on the contrary, they in-
creased T cell proliferation in the secondary MLR (Fig. 8 f ). 
Finally, we investigated the effect of pulsing DCs with myelin 
and LPS in a Th17 assay. Indeed, the combination of myelin 
and LPS resulted in the induction of IL-17A secretion by 
T cells (Fig. 8 g) and the up-regulation of the Th17-associated 
transcription factor RORC (Fig. 8 h). These data demonstrate 
that in the absence of DC-SIGN recognition, small myelin 
particles induce a proinflammatory response that is character-
ized by the activation of the inflammasome, increased T cell 
proliferation, and polarization toward a Th17-prone pheno-
type; a hallmark of autoimmune inflammation in MS.
DISCUSSION
We show here that CNS myelin interacts with APCs present 
in the brain and/or draining LNs through the interaction of 
MOG glycans with DC-SIGN, inducing an antiinflamma-
tory/regulatory function. As the MOG–DC-SIGN interaction 
is glycosylation dependent, we postulate that the steady-state 
glycosylation of MOG is essential for the control of immune 
homeostasis in the human brain. Glycosylation is a tightly 
regulated and complex posttranslational modification that is 
fundamental in the modulation of the activities and functions 
of glycoproteins in biological systems. Our data demonstrates 
that changes in the glycosylation machinery of oligodendro-
cytes upon exposure to inflammatory mediators results in a 
decrease in the expression of DC-SIGN–binding glycans on 
myelin, which was confirmed to take place in active MS 
lesions. We present here a thorough characterization of the 
N-glycome of human myelin showing that the most abundant 
glycans on human healthy myelin are immature and (poly)-
fucosylated biantennary N-glycans. Immature N-glycans are 
typically found within the ER and are only expressed in 
mature glycoproteins as a sign of ER stress. Remarkably, we 
found that (poly)fucosylated N-glycans are the most abun-
dant mature form of N-glycans. Besides their well-known 
implications in blood groups, leukocyte adhesion, and em-
bryogenesis, fucosylated glycans have gained much attention 
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et al., 2002; Fabriek et al., 2005b), also in the presence of an-
tiinflammatory cytokines (van Zwam et al., 2009). Interaction 
of these DC-SIGN+ cells with myelin-specific autoreactive 
T cells could set the stage for the induction of anergy or the 
maintenance of memory T reg cells.
It has been established in a variety of studies that the en-
gagement of DC-SIGN with its ligands relays inhibitory sig-
nals to DCs, which keeps them in an immature/tolerogenic state. 
Pathogens such as M. tuberculosis, HIV-1, or C. albicans seem to 
have hijacked this homeostatic mechanism via DC-SIGN to 
In fact, IL-10 expression was found on DC-SIGN+ cells within 
the brain, strongly supporting the existence of an antiinflam-
matory circuit associated with DC-SIGN engagement in the 
healthy human brain. Concomitantly, myelin antigens may 
encounter DC-SIGN+ cells in the cervical LNs, where DC-
SIGN+ DC present antigen to T cells to activate or inhibit 
autoreactive T cells. We have previously described these DC-
SIGN+ cells in the outer zone of the paracortical areas of the 
LNs, where antigen capture takes place, and where myelin 
antigens that arrive via the lymph are often found (de Vos 
Figure 7. Simultaneous DC-SIGN and TLR4 triggering decreases allogeneic T cell proliferation. (a) DCs were pulsed with Lewisb-containing gly-
codendrimers (10 µg/ml) or a mock control (maltoheptaose dendrimer, 10 µg/ml) in the presence or absence of LPS (10 ng/ml) and exposed to allogeneic 
naive CD4+ T cells. T cells were allowed to rest, and then restimulated with LPS-matured DCs. T cell proliferation was measured by 3[H]thymidine incorpo-
ration. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD (n = 5 independent experiments). (b) DCs were pulsed with myelin (10 µg/ml) 
in the presence or absence of LPS (10 ng/ml) and exposed to allogeneic naive CD4+ T cells. T cells were allowed to rest, and then restimulated with LPS-
matured DCs. T cell proliferation was measured by 3[H]thymidine incorporation. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD  
(n = 5 independent experiments). (c) DCs were pulsed with atto633-labeled myelin (10 µg/ml) in the presence or absence of LPS (10 ng/ml) for 1 h and 
sorted according to their myelin content. MyHi DCs were exposed to allogeneic naive CD4+ T cells. T cells were allowed to rest and then restimulated with 
LPS-matured DCs. T cell proliferation was measured by 3[H]thymidine incorporation. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD 
(n = 3 independent experiments). Only 1:25 DC/T cell ratios are shown; 1:50, 1:100, and 1:200 ratios showed essentially the same trend. (d) DCs were 
incubated 6 h with myelin (10 µg/ml) in the presence or absence of LPS (10 ng/ml) and the Raf-1 kinase inhibitor GW5074 (20 µM) or the blocking anti–
DC-SIGN antibody AZN-D1 (20 µg/ml). DCs were then lysed for mRNA isolation and the expression levels of IL-10 were assayed by real time PCR. *, P ≤ 
0.05 (Mann-Whitney U test). Data are shown as the mean ± SD (n = 3 independent experiments). (e) DCs were incubated for 18 h with myelin (10 µg/ml) 
in the presence or absence of LPS (10 ng/ml) and the Raf-1 kinase inhibitor GW5074 (20 µM) or the blocking anti–DC-SIGN antibody AZN-D1 (20 µg/ml). 
Supernatants were harvested and assayed for IL-10 secretion by ELISA. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD (n = 3 inde-
pendent experiments). (f) DCs were pulsed with myelin (10 µg/ml) in the presence or absence of LPS (10 ng/ml) and the Raf-1 kinase inhibitor GW5074 
(20 µM) or the blocking anti–DC-SIGN antibody AZN-D1 (20 µg/ml), and exposed to allogeneic naive CD4+ T cells. T cells were allowed to rest and then 
restimulated with LPS-matured DCs. T cell proliferation was measured by 3[H]thymidine incorporation. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown 
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release of degraded myelin during overt inflammation or in-
jury, as oligodendrocyte exposure to inflammatory cues re-
sults in decreased expression of the fucosyltransferases involved 
in the synthesis of DC-SIGN ligands. Based on the findings 
reported here, we propose that the physiological role of DC-
SIGN in the healthy CNS is to maintain immune homeostasis 
via the interaction with self-glycoproteins. We further speculate 
that defects in the glycosylation of MOG caused by glycosyl-
transferase polymorphisms or a dysregulation of glycosylation 
avoid immune activation (Geijtenbeek and Gringhuis, 2009). 
Interaction of large myelin particles that are LTA+ and MOGHi 
with DC-SIGN reflects the interaction of intact myelin with 
microglia in vivo, as lipid rafts are still intact in the large parti-
cles and support high avidity interactions with DC-SIGN. 
Furthermore, the mechanism of DC-SIGN activation and 
signaling seem to be similar to that previously described for 
pathogens (Gringhuis et al., 2007). On the contrary, the effect 
of smaller LTAMOGLo myelin particles may represent the 
Figure 8. Defucosylated or small myelin 
particles are proinflammatory. (a) Myelin 
was defucosylated using bovine kidney (1–2, 
3, 4, 6)-Fucosidase. Defucosylation was veri-
fied by assaying the binding of the fucose 
specific plant lectins Lotus tetragonolobus 
(LTA) and Ulex europaeus (UEA-I) agglutinins, 
as well as the binding of recombinant DC-
SIGN and the presence of MOG using the Z12 
antibody on myelin (2 µg/ml) coated plates. 
(b) DCs were incubated 6 h with myelin  
(10 µg/ml) or defucosylated myelin (10 µg/ml) 
in the presence or absence of LPS (10 ng/ml). 
DCs were then lysed for mRNA isolation and 
the expression levels of IL-10 assayed by real-
time PCR. *, P ≤ 0.05 (Mann-Whitney U test). 
Data are shown as the mean ± SD (n = 3  
independent experiments). (c) DCs were  
incubated 18 h with myelin (10 µg/ml) or 
defucosylated myelin (10 µg/ml) in the pres-
ence or absence of LPS (10 ng/ml). Super-
natants were harvested and assayed for IL-10 
secretion by ELISA. *, P ≤ 0.05 (Mann-Whitney 
U test). Data are shown as the mean ± SD  
(n = 3 independent experiments). (d) DCs were 
pulsed with myelin (10 µg/ml) or defucosyl-
ated myelin (10 µg/ml), with or without LPS 
(10 ng/ml), and exposed to allogeneic naive 
CD4+ T cells. T cells were allowed to rest  
and then restimulated with LPS-matured  
DCs. T cell proliferation was measured by 
3[H]thymidine incorporation. *, P ≤ 0.05 
(Mann-Whitney U test). Data are shown as 
the mean ± SD (n = 5 independent experi-
ments). Only 1:25 DC/T cell ratios are shown; 
1:50, 1:100, and 1:200 ratios showed essen-
tially the same trend. (e) DCs were incubated 
with myelin (10 µg/ml) in the presence or 
absence of LPS (10 ng/ml). Caspase-1 activa-
tion was measured by FACS using the fluores-
cent caspase-1 inhibitor Fam-YVAD-Fmk. rATP 
(5 mM) was used as positive control for inflammasome activation. Representative dot plots of experiments (n = 3) performed in duplicate are shown. The 
mean ± SD of the gated regions in the three independent experiments are displayed. *, P ≤ 0.05 (Mann-Whitney U test). (f) DCs were pulsed with atto633-
labeled myelin (10 µg/ml) with or without LPS (10 ng/ml) for 1 h and sorted according to myelin content. MyLo DCs were exposed to allogeneic naive CD4+ 
T cells. T cells were allowed to rest and then restimulated with LPS-matured DCs. T cell proliferation was measured by 3[H]thymidine incorporation.  
*, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD (n = 3 independent experiments). Only 1:25 DC:T cell ratios are shown; 1:50, 1:100, 
and 1:200 ratios showed essentially the same trend. (g) DCs were pulsed with myelin (10 µg/ml) overnight and co-cultured with allogeneic memory CD4+  
T cells. T cells were restimulated with IL-2 (104 IU/ml) twice over 2 wk and supernatants were assayed for IL-17 secretion by ELISA. Peptidoglycan (PGN; 
10 µg/ml) was used as a positive control for Th17 skewing. *, P ≤ 0.05 (Mann-Whitney U test). Data are shown as the mean ± SD (n = 3 independent  
experiments). (h) T cells from g were lysed and their mRNA assayed for the relative abundance of RORC. *, P ≤ 0.05 (Mann-Whitney U test). Data are 
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using the Fmoc strategy of solid-phase peptide synthesis. The peptide was 
coupled to generation 3 PAMAM dendrimers (Sigma-Aldrich) using 4-[2-
[2-(tert-butoxycarbonylamino)ethyldisulfanyl]ethylamino]-4-oxo-butanoic 
acid as a linker. After coupling the glycan (Dextra) to MPBH (Thermo Fisher 
Scientific), the resulting compound was conjugated to the dendrimer.
Cells. Immature DCs were generated from CD14+ monocytes obtained 
from human peripheral blood mononuclear cells isolated from buffy coats by 
Ficoll gradient and CD14 magnetic microbeads isolation (Miltenyi Biotec) 
that were cultured for 6 d in RPMI 1640 medium (Invitrogen) supplemented 
with 10% FCS (BioWhittaker), 2 mM l-glutamine (Life Technologies), 
30 µg/ml penicillin/streptomycin (Life Technologies), and IL-4/GM-CSF 
(ImmunoTools; 500 and 800 U/ml, respectively). Primary glia culture was 
obtained with informed consent from 3 g of human brain tissue from an 
epileptic patient (for microglia culture) or from nondiseased rhesus macaques 
(for oligodendrocyte culture) and microglia or oligodendrocytes were ob-
tained as previously described (de Groot et al., 2001). Primary human astro-
cytes were a gift from M. Mizee (VU University Medical Center, Amsterdam, 
Netherlands). Chinese Hamster Ovary (CHO) cells were cultured in RPMI-
1640 supplemented with 10% FCS and 100 U/ml penicillin–streptomycin. 
The Lec12 glycosylation mutant (Patnaik et al., 2004) was derived from 
CHO cells and a gift from P. Stanley (Albert Einstein College of Medicine, 
Bronx, NY). Cells were transiently transfected with a plasmid encoding the 
full-length transcript of human MOG (pCDNA3.1-huMOG; a kind gift of 
Dr. D. Pham-Dinh, University of Paris) using Lipofectamine (Invitrogen). 
MO3.13 were a gift from P. Stinissen (University of Hasselt, Diepenbeek, 
Belgium) and were cultured, as previously described (Buntinx et al., 2003), in 
DMEM (Life Technologies) supplemented with 10% FCS, 50 U/ml penicil-
lin, and 50 µg/ml streptomycin. MO3.13 cells were differentiated in DMEM 
without FCS, supplemented with 100 nM 4--phorbol 12-myristate 13- 
acetate (PMA; Sigma-Aldrich) after 70% confluency was reached. HEK293-
TLR4/MD2 co-transfectants were grown in RPMI-1640 supplemented 
with 10% FCS, 104 U/ml penicillin, 104 U/ml streptomycin, 2 mM l-glutamine, 
and 1 mg/ml G418 (Invitrogen). For LPS content determination, a total of 
105 cells in 100 µl RPMI were plated onto 96-well flat-bottom plates and 
stimulated with a titration of E. coli LPS. Subsequently, supernatants were an-
alyzed for IL-8 production by ELISA according to the manufacturer’s guide-
lines (Biosource).
FACS and sorting. All FACS data were collected on a FACSCalibur (BD) 
and analyzed using CellQuest Pro (BD) software. For sorting, cells were in-
cubated with atto633-labeled myelin for 4 h at 37°C in 5% CO2 atmosphere 
and sorted using the MoFlo High Speed Sorter (Dako) in 20% FCS DC cul-
ture medium by gating on high or low fluorescence with atto633-myelin. 
Myelin was labeled with NHS-atto633 (Sigma-Aldrich) before the experi-
ment according to manufacturer’s instructions. Autofluorescent cells were 
excluded. Purity and viability of the sorted samples was determined by re-
analysis on the cell sorter. Sorting for MyHi and MyLo populations resulted in 
85–90% pure populations.
Imaging FACS. Cells were acquired on the ImageStreamX (Amnis Corp.) 
imaging flow cytometer at 60× magnification and on the basis of their area 
(area = the number of pixels in an image reported in square micrometers). 
The minimum area for acquisition was set to 50 pixels. A minimum of 15,000 
cells was acquired per sample at a flow rate ranging between 50 and 100 
cells/s. At least 2,000 cells were acquired from single stained samples to allow 
for compensation. Compensation samples were acquired with all channels 
habilitated and with the bright-field illumination and the 785-nm laser 
switched off. A minimum of 5,000 cells from the single-stained samples were 
acquired with the same settings as experimental samples to control for over/
under compensation. Analysis was performed using the IDEAS v5.0 software 
(Amnis Corp.). A compensation table was generated using the compensation 
macro built in the software. Single-stained samples were manually gated for 
accurate calculation of spectral overlap coefficients (Ortyn et al., 2006). Once 
the compensation table was calculated for each of the staining sets, it was applied 
or reduction of DC-SIGN expression may abrogate the ca-
pacity of the MOG–DC-SIGN axis to maintain tolerance. 
According to studies in a nonhuman primate (Callithrix jac-
chus) induction of T cell immunity against epitopes encom-
passed within the extracellular domain of MOG is essential 
for the induction of MS-like pathology and neurological de-
fects (Jagessar et al., 2010). In line with this concept, recent 
evidence shows the importance of glycosylation and DC in 
the maintenance of immune homeostasis: -mannosidase II–
deficient mice are characterized by the expression of immature 
N-glycans that resemble pathogenic carbohydrate structures 
and trigger spontaneous autoimmunity (Green et al., 2007), 
and that loss of DC leads to a loss of T reg cells and, conse-
quently, to autoimmunity (Darrasse-Jèze et al., 2009). The 
lack of control on microglia maturation may cause an altered 
response by microglia to CNS injury, resulting in the loss of 
peripheral tolerance to MOG and the development of CNS 
autoimmunity. Therefore, the reported observations not only 
have broad implications for the mechanisms that control pe-
ripheral tolerance, but also provide new possibilities for the 
development of therapeutic applications in neuroinflamma-
tion beyond MS.
MATERIALS AND METHODS
Myelin. Human CNS white matter tissue was obtained with informed con-
sent at autopsy from three individuals without a history of neuroimmuno-
logical disease, in collaboration with the Dutch Brain Bank (Project #513). 
The Dutch Brain Bank obtained permission from its donors for brain 
autopsy and the use of tissue and clinical information for research pur-
poses. The Dutch Brain Bank donor program has been approved by the Ethi-
cal Committee VU University Medical Center (Amsterdam, Netherlands). 
Myelin was isolated by homogenization and sucrose gradient centrifugation 
(Norton and Poduslo, 1973). Protein concentration in myelin was then as-
sessed by the bicinchoninic acid method (Thermo Fisher Scientific) and la-
beled with NHS-activated Atto633 (Sigma-Aldrich). LPS content was assessed 
by incubation with HEK293-TLR4/MD2 co-transfectants, as previously 
described (Singh et al., 2009).
Glycan analysis. Before immunoprecipitation of MOG, myelin was sub-
jected to delipidation by methanol/chloroform extraction. The pooled pro-
tein phase was then lyophilized, dissolved in a chaotropic detergent solution, 
and sonicated in the presence of -mercaptoethanol. IGEPAL CA-630 was 
used to neutralize the chaotropic detergents before immunoprecipitation 
with anti-MOG (Z12)-coupled Sepharose beads. Both myelin and MOG 
glycans were resolved as previously described (Kalay et al., 2012). MOG was 
identified from the immunoprecipitate after deglycosylation by reduction, 
alkylation, and trypsinization of the recovered material and resolved by load-
ing onto a reverse-phase peptide trap column and separation on a reverse-
phase C18 HPLC directly coupled to a LCQ Deca XP Plus ion trap mass 
spectrometer equipped with a nanospray ionization source. The spray voltage 
was 2.0 kV and the capillary temperature was 150°C. The ion-trap collision 
fragmentation spectra were obtained using collision energies of 35%. Each 
full-scan mass spectrum was followed by three Data Dependent MS/MS 
spectra of the three most intense peaks. The Dynamic Exclusion feature was 
enabled and peptides and proteins were identified automatically by the com-
puter program BioWorks version 3.1. Peptide identification was evaluated 
using the Xcorr versus Charge State filter, which accepts only peptides with 
Xcorr values of 2.5 for singly, doubly, or triply charged precursor ions.
Glycodendrimers. The peptide sequence CEEKSIINFEKLKEEK was pre-
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R. Doms (University of Pennsylvania), as well as the polyclonal goat anti-sera 
CSRD. Biotinylated lectins were counterstained using streptavidin-HRP (In-
vitrogen). Alexa Fluor–conjugated antibodies were purchased from Invitrogen.
Immunohistochemistry and immunofluorescence microscopy. Brain 
tissue from seven human controls with nonneurological disease and seven 
patients with clinically diagnosed and neuropathologically confirmed sec-
ondary progressive MS was obtained at rapid autopsy and immediately frozen 
in liquid nitrogen (Project #513, Dutch Brain Bank). All donors, or their 
next of kin, had given informed consent for autopsy and use of their brain 
tissue for research purposes. Permission to perform autopsies, use of tissue, 
and for access to medical records for research purposes was received from the 
Ethical Committee of the VU University Medical Center (Amsterdam, 
Netherlands). White matter MS tissue samples were selected by postmortem 
MRI, as previously described (De Groot et al., 2001). For immunohisto-
chemical stainings, 5-µm serial cryosections were air dried and fixed in ace-
tone. Sections were blocked with normal serum before incubation with 
primary antibodies and subsequently incubated with the biotinylated appro-
priate secondary antibody. After incubating for 60 min with streptavidin–
HRP complex, peroxidase labeling was visualized by 3,3-diaminobenzidine 
(Sigma-Aldrich). Finally, tissue sections were counterstained with hematoxy-
lin and mounted. Between all incubation steps, the sections were extensively 
washed in PBS. For immunofluorescence, Alexa Fluor 488– and Alexa Fluor 
594–conjugated secondary antibodies were used. Analysis was performed on 
a standard epifluorescence microscope (Nikon DM6000).
Confocal laser-scanning microscopy. Stained cells were allowed to ad-
here to poly-L-lysine–coated glass slides (Sigma-Aldrich) and mounted with 
antibleach reagent (Vector Laboratories). Samples were analyzed using a 
63×/1.4 HCX PL APO CS oil objective on a TCS SP2 AOBS confocal mi-
croscope (Leica). Images were acquired using LCS 2.61 (Leica) and processed 
using ImageJ (National Institutes of Health).
Electron microscopy. Myelin particles were dried on carbon/formvar-
coated copper mesh grids (Electron Microscopy Sciences) and stained by 
uranyl acetate (Sigma-Aldrich) in methylcellulose (Sigma-Aldrich) before 
analysis by transmission electron microscopy (JEOL 1010; JEOL).
Cytokine measurements. For the detection of cytokines, culture superna-
tants were harvested 24 h after DC activation and frozen at 80°C until 
analysis. Cytokines were measured by ELISA with antibody pairs for human 
IL-6, IL-10, TNF, IL-12p40, and IL-12p70 according to the manufacturer’s 
instructions (eBioscience).
T reg cell/anergy induction assays (secondary MLRs). Naive CD4+CD45+ 
T cells were purified by negative selection (Invitrogen) and cultured with 
allogeneic myelin-stimulated DCs in 24-well plates for 6 d. Primed T cells 
were recovered, washed, and allowed to rest for 3 d in the presence of IL-7 
and IL-15 (ImmunoTools). After 9 d of the primary stimulation, primed 
T cells were washed and restimulated by co-culturing them with LPS-activated 
moDC from the original donor at different ratios. After 6 d, plates were 
pulsed with [3H]thymidine (1 µCi/well; GE Healthcare) for an additional 
18 h and [3H]thymidine incorporation was measured on a Betaplate 1205 
liquid scintillation counter (Wallac-LKB).
DC-driven Th17 differentiation. Total CD4+ T cells were negatively isolated 
from PBMCs and co-cultured with myelin-stimulated allogeneic DC. At day 
3–5, rhuIL-2 (ImmunoTools) was added, and the cultures were expanded for 
the next 12–14 d. Cultures were refreshed once with rhuIL-2 and media at 
days 7–9. Expanded T cells were restimulated on day 12–14 with PMA and 
ionomycin (Sigma-Aldrich) for 6 h, with brefeldin A (Sigma-Aldrich) present 
during the last 5 h. T cells were then fixated on Cytofix/Cytoperm solution 
(BD) and single-cell production of IL-17 and IFN- was determined by intra-
cellular staining (BD) and FACS. Additionally, IL-17 was determined in T cell 
supernatants using an anti–IL-17 antibody pair (ImmunoTools).
to the single staining samples that were acquired using the same settings as 
experimental samples. Proper compensation was then verified by visualizing 
samples in bivariate fluorescence intensity plots.
Next, a template analysis file was generated that include an area versus 
aspect ratio intensity plot and a gradient root mean square (RMS) histogram 
of one of the bright-field channels (Channels 1 and 9). Area is the number of 
squared microns of the cells, whereas the aspect ratio intensity index is the 
result of dividing the minor axis (intensity-weighted) by the major axis (in-
tensity weighted) and describes how round or oblong an object is, but also 
indicates if there are doublets in a population of normally circular cells. The 
gradient RMS feature measures the sharpness quality of an image by detect-
ing large changes of pixel values in the image and is useful for the selection 
of focused objects. The gradient RMS feature is computed using the mean 
gradient of a pixel normalized for variations in intensity levels. Using these 
features, a population of focused single cells (SC/F) was gated. This template, 
together with the corresponding compensation table was applied to all the 
experimental samples acquired. Each of the data files generated was opened 
and the SC/F population gated to a new compensated image file. Compen-
sated image files for each experimental sample were then merged into the 
final analysis file. To calculate the internalization of DC-SIGN, a mask was 
designed that characterizes only the intracellular space of the cells. This mask 
was based on the use of the morphology feature applied to the bright-field 
image on channel 1, and then eroded until the membrane was left out of the 
mask. Because cells are gated on a certain level of focusing it is possible to as-
sume that the image acquired represents, in all cells, a 2.5-µm cross section of 
the major circumference (Ortyn et al., 2007). At this location, the thickness 
of the membrane is similar in all cells and allows us to design a mask based 
exclusively on bright-field images. The intracellular mask was then used to 
calculate the feature internalization applied to the DC-SIGN channel. The 
internalization score is a log-scaled ratio of the intensity inside the cell (intra-
cellular mask) versus the intensity of the entire cell. Cells that have internal-
ized antigen typically have positive scores, whereas cells that show the antigen 
still on the membrane have negative scores. Cells with scores of 0 have 
similar amounts of antigen on the membrane and in intracellular com-
partments. Co-localization is calculated as the logarithmic transformation of 
Pearson’s correlation coefficient of the localized bright spots with a radius of 
3 pixels or less within the whole cell area in the two input images (bright de-
tail similarity R3). Because the bright spots in the two images are either cor-
related (in the same spatial location) or uncorrelated (in different spatial 
locations), the correlation coefficient varies between 0 (uncorrelated) and 
1 (perfect correlation). The logarithmic transformation of the correlation co-
efficient allows the use of a wider range for the colocalization score.
Antibodies and lectins. The following antibodies were purchased from 
BD: CD80-PE (L307.4, IgG1), CD86-PE (2331, IgG1), HLA A/B/C-PE 
(G46-2.6, IgG1), HLA DR-PE (G46.6, IgG2a), CD11c-APC (B-ly6, IgG1), 
CD31-FITC (M89D3, IgG2a), and DC-SIGN-FITC (CD209, 120507, 
IgG2b). Anti–CD83-PE (HB15a, IgG2b) was supplied by Beckman Coulter. 
The antibody against CD62L-FITC (LT-TD180, IgG1) was obtained from Im-
munotools. The antibody against PLP (plpc1, IgG2a) was purchased from AbD 
Serotec. The antibody against GFAP (6F2, IgG1) was obtained from Dako. 
The antibody against NGFR (rabbit polyclonal) was purchased from Abcam. 
The antibody against CD40 was provided by T.D. de Gruijl (VU University 
Medical Center, Amsterdam, Netherlands). The antibodies against PD-L1 and 
4IBB-I were a gift from E.C. de Jong (University of Amsterdam, Amsterdam, 
Netherlands). The biotinylated lectins Lotus tetragonolobus agglutinin (LTA), 
Aleuria aurantia agglutinin (AAL), Ulex europaeus agglutinin I (UEA-I), Griffo-
nia simplicifolia lectin-I isolectin B4 (GSL-I Isolectin B4), Maackia amurensis 
agglutinin (MAA), and Sambucus nigra agglutinin (SNA) were purchased from 
Vector Laboratories. Soluble DC-SIGN in the form of a human recombinant 
Fc chimera (IgG1) or a mouse Fc chimera (IgG2a) was obtained from our 
stocks. Anti-CD11b (bear 1, IgG1), anti-CD11c (Shcl3, IgG2b), AZN-D1 
(IgG1), and Z12 (IgG2a) were purified from hybridoma supernatant using a 
protein A Sepharose FF column (GE Healthcare). Anti–DC-SIGN antibodies 
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